Wolf, J. M., B. Gubert Borges, P. Pereira Fagundes, V. de Souza, A. Brenner, H. Petek, W. Michelon dos Santos, J. Gasparetto Maccari, V. Rohsig, M. Parrini Mutlaq, e L. A. Nasi. “Adverse Drug Events, Comorbidities, and Older Age Are Statistically More Prevalent in COVID-19 Hospitalized Patients Treated With Remdesivir Than Tocilizumab in a Private Hospital from Southern Brazil”. Clinical and Biomedical Research, vol. 43, nº 3, novembro de 2023, https://seer.ufrgs.br/index.php/hcpa/article/view/129384.